Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatic glycogen phosphorylase is an enzyme found in the liver that catalyzes the rate-limiting step in glycogenolysis, the breakdown of glycogen into glucose-1-phosphate. It plays a crucial role in maintaining blood glucose homeostasis. The enzyme is encoded by the *PYGL* gene and exists as a homodimeric protein. It is regulated by phosphorylation/dephosphorylation and allosteric effectors. Mutations in *PYGL* can cause Glycogen Storage Disease Type VI (Hers Disease). Inhibitors are being explored for type 2 diabetes.
Inhibition of glycogenolysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatic Glycogen Phosphorylase (None).